BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9869611)

  • 1. Limited humoral immunity in hepatitis C virus infection.
    Chen M; Sällberg M; Sönnerborg A; Weiland O; Mattsson L; Jin L; Birkett A; Peterson D; Milich DR
    Gastroenterology; 1999 Jan; 116(1):135-43. PubMed ID: 9869611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
    Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus.
    Santos VCD; Schinoni MI; Oliveira IS; Atta MLS; Atta AM
    Rev Soc Bras Med Trop; 2019 Mar; 52():e20180491. PubMed ID: 30843970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic significance of antibody detection to various hepatitis C virus antigens in patients with acute and chronic HCV-infection].
    Iushchuk ND; Ogienko OL; Kruglov IV; Znoĭko OO; Braginskiĭ DM; Semiletov IuA; Finogenova MP; Alekseenkova TI; Ianina MV; Shibnev VA; Doroshenko NV
    Ter Arkh; 2002; 74(4):18-22. PubMed ID: 12043232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
    Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Envelope-Specific IgG3 and IgG1 Responses Are Associated with Clearance of Acute Hepatitis C Virus Infection.
    Walker MR; Eltahla AA; Mina MM; Li H; Lloyd AR; Bull RA
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31936235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of chimeric antibodies against NS3, NS4, NS5, and core antigens of hepatitis C virus.
    Tu B; Ziemann RN; Tieman BC; Hawksworth DJ; Tyner J; Scheffel J; Pinkus MS; Brophy SE; Werneke JM; Gutierrez R; White M
    Clin Vaccine Immunol; 2010 Jun; 17(6):1040-7. PubMed ID: 20427624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
    Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
    J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
    Chu CM; Sheen IS; Liaw YF
    Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia.
    Gabrielli A; Zhang ZX; Cherubini G; Candela M; Savoldi S; Manzin A; Clementi M; Amoroso A; Sallberg M
    Clin Exp Immunol; 1996 Jul; 105(1):59-64. PubMed ID: 8697636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spectrum of antibodies to HCV antigens in patients with different clinical patterns of chronic HCV infection].
    Kruglov IV; Znoĭko OO; Ogienko OL; Ianina MV; Finogenova MP; Alekseenkova TI; Braginskiĭ DM; Kuzin SN; Sukhanova LL; Grinev AA; Selivanov NA; Doroshenko NV; Shibnev VA; Semiletov IuA
    Vopr Virusol; 2002; 47(2):11-6. PubMed ID: 12046459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b.
    Carlos MP; Yamamura Y; Vu Q; Conzen K; Anderson DE; Torres JV
    Clin Immunol; 2004 Apr; 111(1):22-7. PubMed ID: 15093548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-specific antibody titres in different phases of hepatitis C virus infection.
    Nikolaeva LI; Blokhina NP; Tsurikova NN; Voronkova NV; Miminoshvili MI; Braginsky DM; Yastrebova ON; Booynitskaya OB; Isaeva OV; Michailov MI; Archakov AI
    J Viral Hepat; 2002 Nov; 9(6):429-37. PubMed ID: 12431205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A correlation between the heterogeneity of hypervariable region 1 of E2 glycoprotein of Hepatitis C virus (HCV) and HCV antibody profile: a case study.
    Kmieciak D; Biernacka-Lukanty J; Migdalski P; Turek-Plewa J; Wierzbicki A; Juszczyk J; Trzeciak WH
    Acta Virol; 2005; 49(2):97-103. PubMed ID: 16047736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein.
    Sällberg M; Rudén U; Wahren B; Magnius LO
    Clin Exp Immunol; 1993 Mar; 91(3):489-94. PubMed ID: 7680297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.